EUCTR2013-000052-17-GB进行中（未招募）不适用
Pilot study to investigate the early prediction of toxicity following induction chemotherapy in Ewing’s sarcoma by blood-borne biomarkers and correlation with age-dependent pharmacokinetic variation - Pharmacokinetic variation and toxicity in Ewing's sarcoma
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •a) Diagnosis of histologically confirmed Ewing sarcoma.
- •b) Receiving VIDE or VDC/IE as part of standard clinical treatment.
- •c) Single or double lumen central venous catheter in place.
- •d) Written informed consent.
- •e) Protocol approval by national and local ethics committee, regulatory authority and Trust R&D Departments.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 90
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 30
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range 0
排除标准
- •a) Receiving non-standard dose chemotherapy.
- •b) Glomerular filtration rate <60 ml/min/1.73m2.
研究者
相似试验
已完成
不适用
Pharmacokinetic variation and toxicity in Ewing's sarcomaEwing's sarcomaCancerISRCTN52616678The Newcastle Upon Tyne Hospitals NHS Foundation Trust (UK)139
尚未招募
不适用
The effect of graduated return to high-intensity exercise on time to return to play in the context of sports-related concussions.Sports-related concussionMild Traumatic Brain InjuryACTRN12618000485235Dr Hamish Osborne50
已完成
1 期
CytoMegaloVirus: Alternate donor Study of Pre-Emptive Cellular TherapyISRCTN75391842Cell Medica Ltd (UK)18
进行中（未招募）
1 期
A prospective phase I/II study to investigate the feasibility, safety and efficacy of IL-15 activated cytokine induced killer (CIK) cells in relapsing patients with acute leukemia or myelodysplastic syndromes after allogeneic stem cell transplantatiorelapsing acute leukemia, relapsing myelodysplastic syndromesMedDRA version: 17.0Level: LLTClassification code 10000835Term: Acute leukemiaSystem Organ Class: 100000004864MedDRA version: 17.0Level: HLTClassification code 10028536Term: Myelodysplastic syndromesSystem Organ Class: 100000004851EUCTR2013-005446-11-DEGoethe-University Frankfurt40
招募中
不适用
A randomized pilot study to search the predictive parameters of PSK responder in patients with colorectal cancercolorectal cancerJPRN-UMIN000010046Department of Digestive Surgery and Surgical Oncology, Yamaguchi University Graduate School of Medicine210